you are here: Home News Weight Loss Drug

Weight Loss Drug

How Eli Lilly’s weight-loss drug Mounjaro gained early lead against Novo Nordisk’s Wegovy in India
Roche to buy 89bio for up to $3.5 billion in obesity push
India bulk drug makers start preparing for Ozempic patent expiry
Chart of the Day: Weight loss drugs are making their presence felt in Indian pharma market
Lilly to launch Mounjaro pen in India to compete with Novo's weight-loss drug Wegovy
Novo Nordisk launches blockbuster weight loss drug Wegovy in India
Mounjaro side effects revealed: Decreased appetite, mild nausea and more
Is Ozempic beneficial for you? Nutritionist explains how it can diminish your natural glow
Eli Lilly may manufacture weight-loss drug Mounjaro in India in future, says CEO David Ricks
Move over Ozempic. Mounjaro is the new weight loss drug in the market
Eli Lilly plans launch of weight-loss drug in emerging markets by 2026, CFO says
Ozempic: A miracle weight-loss drug or dangerous trend? We examine
Weight loss drug opportunity is increasingly coming into focus for Indian pharma
Novo Nordisk falls most on record after new weight drug disappoints
Morepen Labs forays into obesity market with nutrition products and health-tracking app
Health benefits of matcha tea: The superfood to lose weight, boost immunity, keep skin smooth
Weight-Loss Drug Sales Forecast To Hit $150 Billion By 2030 | Wegovy & Zepbound Lead The Charge
Open to market Eli Lilly’s weight loss drugs in India: Cipla CEO
Biocon leads India push into weight loss drugs as patents lapse
Ozempic obsession: Hollywood’s weight loss fixation; why it is in spotlight once again
Anti-Obesity Drug: Science Finally Lets You Lose Weight Without Diet Or Exercise

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Weight Loss Drug

How Eli Lilly’s weight-loss drug Mounjaro gained early lead against Novo Nordisk’s Wegovy in India

Roche to buy 89bio for up to $3.5 billion in obesity push

India bulk drug makers start preparing for Ozempic patent expiry

Chart of the Day: Weight loss drugs are making their presence felt in Indian pharma market

Lilly to launch Mounjaro pen in India to compete with Novo's weight-loss drug Wegovy

Novo Nordisk launches blockbuster weight loss drug Wegovy in India

Mounjaro side effects revealed: Decreased appetite, mild nausea and more

Is Ozempic beneficial for you? Nutritionist explains how it can diminish your natural glow

Eli Lilly may manufacture weight-loss drug Mounjaro in India in future, says CEO David Ricks

Move over Ozempic. Mounjaro is the new weight loss drug in the market

Eli Lilly plans launch of weight-loss drug in emerging markets by 2026, CFO says

Ozempic: A miracle weight-loss drug or dangerous trend? We examine

Weight loss drug opportunity is increasingly coming into focus for Indian pharma

Novo Nordisk falls most on record after new weight drug disappoints

Morepen Labs forays into obesity market with nutrition products and health-tracking app

Health benefits of matcha tea: The superfood to lose weight, boost immunity, keep skin smooth

Weight-Loss Drug Sales Forecast To Hit $150 Billion By 2030 | Wegovy & Zepbound Lead The Charge

Open to market Eli Lilly’s weight loss drugs in India: Cipla CEO

Biocon leads India push into weight loss drugs as patents lapse

Ozempic obsession: Hollywood’s weight loss fixation; why it is in spotlight once again

Anti-Obesity Drug: Science Finally Lets You Lose Weight Without Diet Or Exercise